Jia Bing Dai

Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China.

Shanghai Pharmaceutical (Group) Co., Ltd. engages in the research of medical products and medical devices and related products. Its business activities include manufacture, sale, installation, and maintenance of medical equipment; industrial investment; and import and export business. The company was founded on April 23, 1997 and is headquartered in Shanghai, China.